Elevance Health Past Earnings Performance
Past criteria checks 3/6
Elevance Health has been growing earnings at an average annual rate of 7.1%, while the Healthcare industry saw earnings growing at 18.2% annually. Revenues have been growing at an average rate of 11.2% per year. Elevance Health's return on equity is 14.6%, and it has net margins of 3.7%.
Key information
7.1%
Earnings growth rate
9.1%
EPS growth rate
| Healthcare Industry Growth | 11.6% |
| Revenue growth rate | 11.2% |
| Return on equity | 14.6% |
| Net Margin | 3.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Elevance Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 174,015 | 6,418 | 37,383 | 0 |
| 30 Jun 24 | 171,719 | 6,691 | 37,407 | 0 |
| 31 Mar 24 | 171,745 | 6,244 | 36,666 | 0 |
| 31 Dec 23 | 171,340 | 5,987 | 36,236 | 0 |
| 30 Sep 23 | 168,626 | 5,996 | 35,718 | 0 |
| 30 Jun 23 | 165,716 | 6,310 | 33,553 | 0 |
| 31 Mar 23 | 160,676 | 6,094 | 31,749 | 0 |
| 31 Dec 22 | 156,599 | 5,894 | 30,696 | 0 |
| 30 Sep 22 | 153,251 | 6,166 | 29,605 | 0 |
| 30 Jun 22 | 149,134 | 6,072 | 28,496 | 0 |
| 31 Mar 22 | 144,353 | 6,228 | 27,590 | 0 |
| 31 Dec 21 | 138,643 | 6,158 | 26,604 | 0 |
| 30 Sep 21 | 133,883 | 5,518 | 26,357 | 0 |
| 30 Jun 21 | 129,219 | 4,231 | 25,839 | 0 |
| 31 Mar 21 | 124,632 | 4,714 | 25,675 | 0 |
| 31 Dec 20 | 121,868 | 4,572 | 25,202 | 0 |
| 30 Sep 20 | 117,449 | 4,955 | 23,013 | 0 |
| 30 Jun 20 | 112,965 | 5,916 | 20,850 | 0 |
| 31 Mar 20 | 109,167 | 4,779 | 17,955 | 0 |
| 31 Dec 19 | 104,212 | 4,807 | 15,356 | 0 |
| 30 Sep 19 | 100,165 | 4,298 | 14,323 | 0 |
| 30 Jun 19 | 96,742 | 4,074 | 13,706 | 0 |
| 31 Mar 19 | 94,220 | 3,989 | 13,758 | 0 |
| 31 Dec 18 | 92,091 | 3,750 | 14,020 | 0 |
| 30 Sep 18 | 91,409 | 4,556 | 13,681 | 0 |
| 30 Jun 18 | 90,584 | 4,344 | 13,146 | 0 |
| 31 Mar 18 | 90,061 | 4,145 | 12,772 | 0 |
| 31 Dec 17 | 90,049 | 3,843 | 12,650 | 0 |
| 30 Sep 17 | 89,055 | 2,980 | 12,520 | 0 |
| 30 Jun 17 | 88,038 | 2,851 | 12,634 | 0 |
| 31 Mar 17 | 87,083 | 2,777 | 12,549 | 0 |
| 31 Dec 16 | 84,862 | 2,470 | 12,559 | 0 |
| 30 Sep 16 | 83,364 | 2,282 | 12,562 | 0 |
| 30 Jun 16 | 81,866 | 2,319 | 12,518 | 0 |
| 31 Mar 16 | 80,412 | 2,398 | 12,590 | 0 |
| 31 Dec 15 | 79,158 | 2,560 | 12,535 | 0 |
| 30 Sep 15 | 77,959 | 2,886 | 12,299 | 0 |
| 30 Jun 15 | 76,605 | 2,862 | 12,187 | 0 |
| 31 Mar 15 | 75,066 | 2,734 | 12,032 | 0 |
| 31 Dec 14 | 73,886 | 2,560 | 11,748 | 0 |
| 30 Sep 14 | 72,792 | 2,362 | 11,361 | 0 |
| 30 Jun 14 | 72,090 | 2,385 | 10,936 | 0 |
| 31 Mar 14 | 71,307 | 2,453 | 10,485 | 0 |
| 31 Dec 13 | 71,024 | 2,634 | 9,953 | 0 |
Quality Earnings: E1LV34 has high quality earnings.
Growing Profit Margin: E1LV34's current net profit margins (3.7%) are higher than last year (3.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: E1LV34's earnings have grown by 7.1% per year over the past 5 years.
Accelerating Growth: E1LV34's earnings growth over the past year (7%) is below its 5-year average (7.1% per year).
Earnings vs Industry: E1LV34 earnings growth over the past year (7%) did not outperform the Healthcare industry 64.3%.
Return on Equity
High ROE: E1LV34's Return on Equity (14.6%) is considered low.